Predictive Value of LINC01133 for Unfavorable Prognosis was Impacted by Alcohol in Esophageal Squamous Cell Carcinoma

Abstract

Background/Aims: Considerable evidence indicates that long noncoding RNAs (lncRNAs) exert importantly regulatory functions during human cancer initiation and progression and are promising biotargets in the flight against cancer. Methods: In this study, we evaluated the role of the lncRNA LINC01133 in esophageal squamous cell carcinoma (ESCC). LINC01133 expression in ESCC was examined by quantitative real-time PCR. The correlations between LINC01133 expression and clinicopathological variables and survival were examined by the χ² test, Kaplan–Meier method, log-rank test, and univariate Cox regression analysis. Results: LINC01133 expression levels were frequently lower in ESCC tissues and cell lines than in paired normal tissues and an immortalized esophageal epithelial cell line, respectively. The expression of LINC01133 decreased in a TNM stage- and lifestyle-independent manner. LINC01133 was an independent protective factor and had an anti-tumor effect in the early stage of ESCC development. More importantly, we discovered that drinking status in our cohort impaired the predictive accuracy of LINC01133 for patients with ESCC. Furthermore, a new risk model combining LINC01133 expression, drinking status, and TNM stage provided better survival discrimination compared with three other predictors. Conclusions: Our data indicate that a loss of LINC01133 expression is a potential poor prognostic biomarker and therapeutic target for ESCC and provide additional prognostic information to improve the outcomes of ESCC patients.

LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression

“…LncRNAs were previously regarded as “junk” or transcriptional noise owing to lack of protein-coding capacity, but more and more emerging evidences have demonstrated that lncRNAs exhibit complicated functions in gene transcription and protein regulation 7,8 . As expected, lncRNAs are considered as a new class of indispensable regulators involved in the progression and metastasis of cancer 9,10 . In gastric cancer, upregulation of lncRNA HOTAIR, MALAT1 and Linc00152 promoted cancer migration and invasion via several mechanisms including competitive endogenous RNA (ceRNA), epigenetic modification, transcription regulation, et al 11–13 .…”

LINC00473 contributes to the radioresistance of esophageal squamous cell carcinoma by regulating microRNA‑497‑5p and cell division cycle 25A

“…lncRNAs can be categorized as oncogenes and/or tumor suppressors depending on the specific malignancy (11,12), and the aberrant expression of lncRNAs can be used to evaluate the tumorigenesis, progression and relapse of malignant tumors. For example, LINc01133 can be used to predict the progression of EScc with high sensitivity and specificity (13), and the upregulation of lncRNA HOX transcript antisense RNA indicates a poor prognosis and early-onset metastasis in patients with EScc (14). Furthermore, lncRNAs have been demonstrated to modulate the radiosensitivity of ESCC cells.…”

Tumor-suppressive miR-3650 inhibits tumor metastasis by directly targeting NFASC in hepatocellular carcinoma

“…As the development of high-throughput transcriptome analysis and next generation sequencing, it has been recognized that up to 90% of genomic DNA are not transcribed and translated into proteins [8], but they can be transcribed into noncoding RNAs [9]. MiRNAs are a class of 18-22 nucleotide small noncoding RNAs that can negatively regulate target genes expression by partially base-pairing with the 3 untranslated regions (3’-UTR) of target mRNAs [10].…”